TechnoMark News

Shingles is known as Herpes Zoster which causes a blistering painful rash on the skin which lasts from 2 to 4 weeks. But, for some people, the pain may last for months or years. This pain is called as (PHN) Post Herpetic Neuralgia, which is a common complication of shingles and it’s occurrence increases with age. Some of the players in global shingles vaccine market: Merck& Co., Inc. (U.S.), GlaxoSmithKline plc (UK), Cipla Inc. (India), Pfizer Inc. (U.S.) Increase in the prevalence and incidence of shingles disease around the world and increase in the global ageing population is expected to enhance the growth of shingles vaccine market across the globe. But, lack of awareness, high cost of the vaccination, unfavourable insurance coverage is major restraints of the global shingles vaccine market. Read More @  https://www.medgadget.com/2021/01/shingles-vaccine-market-2019-2025-trends-technology-opportunities-and-forecasts-by-2025.html

Shingles vaccine market was estimated to be US$ 2,495.0 million by 2025. It is anticipated to grow at a CAGR of ~17.9% from 2020 to 2030. Shingles is an infectious disease which is caused by the reactivation of the chickenpox virus or herpes zoster. The common symptoms associated with this infection are development of rashes, ulcers blister and redness on the skin; exhaustion, and itching among others. Vaccines available for the treatment of shingles are Zostavax, Shingrix & SkyZoster, which are manufactured by Merck & Co., Inc., GlaxoSmithKline plc & SK chemicals respectively. Major Key Players of the Shingles Vaccine Market are: GlaxoSmithKline plc., and Merck & Co., Inc.. and SK Chemicals Read More @  https://www.medgadget.com/2020/11/shingles-vaccine-market-size-competitive-strategies-application-analysis-regional-and-forecasts-2020-to-2030.html

Shingles is known as Herpes Zoster which causes a blistering painful rash on the skin which lasts from 2 to 4 weeks. But, for some people, the pain may last for months or years. This pain is called as (PHN) Post Herpetic Neuralgia, which is a common complication of shingles and it’s occurrence increases with age. Some of the players in global shingles vaccine market: Merck& Co., Inc. (U.S.), GlaxoSmithKline plc (UK), Cipla Inc. (India), Pfizer Inc. (U.S.) Increase in the prevalence and incidence of shingles disease around the world and increase in the global ageing population is expected to enhance the growth of shingles vaccine market across the globe. But, lack of awareness, high cost of the vaccination, unfavourable insurance coverage is major restraints of the global shingles vaccine market. Read More @  http://themarketpublicist.com/2020/06/21/shingles-vaccine-market-2019-2025-trends-technology-opportunities-and-forecasts-by-2025/